Debanjana Chatterjee
Stock Analyst at Jones Trading
(n/a)
# 4,407
Out of 4,761 analysts
5
Total ratings
n/a
Success rate
-20.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGMT Sagimet Biosciences | Initiates: Buy | $42 | $4.12 | +919.42% | 1 | Jan 27, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Hold | n/a | $21.29 | - | 1 | Dec 11, 2024 | |
| KALV KalVista Pharmaceuticals | Initiates: Buy | $35 | $10.03 | +248.95% | 1 | Sep 27, 2024 | |
| PHVS Pharvaris | Initiates: Buy | $46 | $16.49 | +178.96% | 1 | Sep 19, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Buy | $41 | $12.17 | +236.89% | 1 | Sep 17, 2024 |
Sagimet Biosciences
Jan 27, 2025
Initiates: Buy
Price Target: $42
Current: $4.12
Upside: +919.42%
Spyre Therapeutics
Dec 11, 2024
Initiates: Hold
Price Target: n/a
Current: $21.29
Upside: -
KalVista Pharmaceuticals
Sep 27, 2024
Initiates: Buy
Price Target: $35
Current: $10.03
Upside: +248.95%
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $16.49
Upside: +178.96%
Intellia Therapeutics
Sep 17, 2024
Initiates: Buy
Price Target: $41
Current: $12.17
Upside: +236.89%